Concord Drugs Ltd Q1 FY2026-2027 Results: Summary
Revenue | ₹20.95Cr |
Net Profits | ₹1.11Cr |
Net Profit Margins | 5.30% |
Concord Drugs Ltd’s revenue jumped 53.93% since last year same period to ₹20.95Cr in the Q1 2026-2027. On a quarterly growth basis, Concord Drugs Ltd has generated -44.72% fall in its revenue since last 3-months.
Concord Drugs Ltd’s net profit jumped 825% since last year same period to ₹1.11Cr in the Q1 2026-2027. On a quarterly growth basis, Concord Drugs Ltd has generated 109.43% jump in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin jumped 500.92% since last year same period to 5.30% in the Q1 2026-2027. On a quarterly growth basis, Concord Drugs Ltd has generated 278.88% jumped in its net profit margins since last 3-months.
FAQs
What was the revenue for Concord Drugs Ltd in Q1 results 2026?
The revenue for Concord Drugs Ltd in the Q1 results 2026 was ₹20.95Cr.
What was the net profit for Concord Drugs Ltd in Q1 results 2026?
The net profit for Concord Drugs Ltd in the Q1 results 2026 was ₹1.11Cr.
What was the net profit margin for Concord Drugs Ltd in Q1 results 2026?
The net profit margin for Concord Drugs Ltd in the Q1 results 2026 was 5.30%.
What was the revenue for Concord Drugs Ltd in Q1 results 2025?
The revenue for Concord Drugs Ltd in the Q1 results 2025 was ₹13.61Cr.
What was the net profit for Concord Drugs Ltd in Q1 results 2025?
The net profit for Concord Drugs Ltd in the Q1 results 2025 was ₹0.12Cr.
What was the net profit margin for Concord Drugs Ltd in Q1 results 2025?
The net profit margin for Concord Drugs Ltd in the Q1 results 2025 was 0.88%.
